Embattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead

(MedPage Today) — For a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform, the much-litigated Myval performed well enough in the COMPARE-TAVI 1 randomized trial, but its rates of pacemakers and paravalvular leaks…

Source link : https://www.medpagetoday.com/cardiology/pci/114984

Author :

Publish date : 2025-04-04 21:44:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Embattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead

Switch to Tirzepatide in T2D More Effective Than Upping Dulaglutide Dose

How a home DNA test finally revealed the truth

Related Posts

VA Restricts Research Publishing; Makary Bashes CDC Committee; Musk’s Drug Use

Novel Algorithm Boosts Stroke Triage, Outcomes Across the US

Trillion dollars’ worth of platinum waiting to be mined on the moon

ADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast Cancer

Measles Update: Where Are We Now?

Manslaughter case launched into Nottingham baby deaths

VA Restricts Research Publishing; Makary Bashes CDC Committee; Musk’s Drug Use

Novel Algorithm Boosts Stroke Triage, Outcomes Across the US

Trillion dollars’ worth of platinum waiting to be mined on the moon

ADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast Cancer

Measles Update: Where Are We Now?

Manslaughter case launched into Nottingham baby deaths

Dogs pollute water with pesticides even weeks after flea treatment

Teleneurology Bests Onboard Stroke Care Model

Categories

Archives